{
    "nct_id": "NCT04822597",
    "official_title": "Optimizing Topical Pain Control for Breast Cancer Patients Undergoing Pre-operative Radiotracer Injection for Sentinel Lymph Node Mapping",
    "inclusion_criteria": "* greater than or equal to 18 years of age\n* biopsy proven breast cancer\n* standard radiotracer injection (intradermal injection in the upper outer quadrant of the involved breast)\n* radiotracer injection occurs on the same day as sentinel lymph node surgery\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* males\n* pregnancy\n* local anesthetic allergy or active use of the following medications:\n\n  * Abametapir (risk X)\n  * Conivaptan (risk X)\n  * Fusidic Acid (risk X)\n  * Idelalisib (risk X)\n  * Mifepristone (risk D)\n  * Stiripentol (risk D)\n  * Amiodarone (risk C)\n  * Dofetilide (risk C)\n  * Dronedarone (risk C)\n  * Ibutilide (risk C)\n  * Sotalol (risk C)\n  * Vernakalant (risk C)\n* Non-English speaking/reading\n* Unable to provide informed consent\n* Unable to participate with surveys\n* Undergoing radiotracer injection the day prior to surgery or intra-operatively at the time of initial surgical scheduling\n\n  * If patients are initially scheduled for same-day preoperative injection, complete all enrollment procedures (including randomization), and surgery is re-scheduled for a day prior to surgery or for intra-operative injection, they will be excluded if:\n\n    * randomized to a lidocaine patch arm (Arms C or D)\n    * re-scheduled for an intra-operative injection â€¢ Planned non-standard radiotracer injection site",
    "miscellaneous_criteria": ""
}